UniProt ID | SLBP_HUMAN | |
---|---|---|
UniProt AC | Q14493 | |
Protein Name | Histone RNA hairpin-binding protein | |
Gene Name | SLBP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 270 | |
Subcellular Localization | Cytoplasm. Nucleus. Polyribosome-associated. Localizes predominantly in the nucleus at the G1/G2 phases and the beginning of S phase. Through the S phase, partially redistributes to the cytoplasm. Binding to histone mRNA is necessary for cytoplasmic | |
Protein Description | RNA-binding protein involved in the histone pre-mRNA processing. Binds the stem-loop structure of replication-dependent histone pre-mRNAs and contributes to efficient 3'-end processing by stabilizing the complex between histone pre-mRNA and U7 small nuclear ribonucleoprotein (snRNP), via the histone downstream element (HDE). Plays an important role in targeting mature histone mRNA from the nucleus to the cytoplasm and to the translation machinery. Stabilizes mature histone mRNA and could be involved in cell-cycle regulation of histone gene expression. Involved in the mechanism by which growing oocytes accumulate histone proteins that support early embryogenesis. Binds to the 5' side of the stem-loop structure of histone pre-mRNAs.. | |
Protein Sequence | MACRPRSPPRHQSRCDGDASPPSPARWSLGRKRRADGRRWRPEDAEEAEHRGAERRPESFTTPEGPKPRSRCSDWASAVEEDEMRTRVNKEMARYKRKLLINDFGRERKSSSGSSDSKESMSTVPADFETDESVLMRRQKQINYGKNTIAYDRYIKEVPRHLRQPGIHPKTPNKFKKYSRRSWDQQIKLWKVALHFWDPPAEEGCDLQEIHPVDLESAESSSEPQTSSQDDFDVYSGTPTKVRHMDSQVEDEFDLEACLTEPLRDFSAMS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
7 | Phosphorylation | -MACRPRSPPRHQSR -CCCCCCCCCCCCCC | 41.77 | 23401153 | |
7 (in isoform 2) | Phosphorylation | - | 41.77 | 27762562 | |
13 | Phosphorylation | RSPPRHQSRCDGDAS CCCCCCCCCCCCCCC | 28.84 | 28450419 | |
20 | Phosphorylation | SRCDGDASPPSPARW CCCCCCCCCCCCCHH | 41.92 | 29255136 | |
23 | Phosphorylation | DGDASPPSPARWSLG CCCCCCCCCCHHHCC | 34.28 | 19664994 | |
23 (in isoform 2) | Phosphorylation | - | 34.28 | 25159151 | |
28 | Phosphorylation | PPSPARWSLGRKRRA CCCCCHHHCCCCCCC | 18.52 | 23090842 | |
59 | Phosphorylation | GAERRPESFTTPEGP CCCCCCCCCCCCCCC | 30.49 | 29255136 | |
61 | Phosphorylation | ERRPESFTTPEGPKP CCCCCCCCCCCCCCC | 51.20 | 29255136 | |
62 | Phosphorylation | RRPESFTTPEGPKPR CCCCCCCCCCCCCCC | 19.82 | 29255136 | |
67 | Ubiquitination | FTTPEGPKPRSRCSD CCCCCCCCCCCCCCH | 65.01 | - | |
70 | Phosphorylation | PEGPKPRSRCSDWAS CCCCCCCCCCCHHHH | 46.28 | 26074081 | |
73 | Phosphorylation | PKPRSRCSDWASAVE CCCCCCCCHHHHHHC | 34.77 | 26074081 | |
77 | Phosphorylation | SRCSDWASAVEEDEM CCCCHHHHHHCHHHH | 28.70 | 26552605 | |
98 | Sumoylation | EMARYKRKLLINDFG HHHHHHHHHHHHCCC | 43.42 | - | |
98 | Ubiquitination | EMARYKRKLLINDFG HHHHHHHHHHHHCCC | 43.42 | - | |
98 | Sumoylation | EMARYKRKLLINDFG HHHHHHHHHHHHCCC | 43.42 | 28112733 | |
110 | Phosphorylation | DFGRERKSSSGSSDS CCCCCCCCCCCCCCC | 35.64 | 28176443 | |
111 | Phosphorylation | FGRERKSSSGSSDSK CCCCCCCCCCCCCCC | 41.58 | 27273156 | |
112 | Phosphorylation | GRERKSSSGSSDSKE CCCCCCCCCCCCCCH | 50.19 | 26074081 | |
114 | Phosphorylation | ERKSSSGSSDSKESM CCCCCCCCCCCCHHH | 32.68 | 30576142 | |
115 | Phosphorylation | RKSSSGSSDSKESMS CCCCCCCCCCCHHHC | 49.80 | 28176443 | |
117 | Phosphorylation | SSSGSSDSKESMSTV CCCCCCCCCHHHCCC | 40.03 | 23401153 | |
120 | Phosphorylation | GSSDSKESMSTVPAD CCCCCCHHHCCCCCC | 23.05 | 29116813 | |
122 | Phosphorylation | SDSKESMSTVPADFE CCCCHHHCCCCCCCC | 35.22 | - | |
123 | Phosphorylation | DSKESMSTVPADFET CCCHHHCCCCCCCCC | 23.13 | 30576142 | |
133 | Phosphorylation | ADFETDESVLMRRQK CCCCCCHHHHHHHHH | 24.30 | - | |
137 | Methylation | TDESVLMRRQKQINY CCHHHHHHHHHHHHC | 33.44 | 30761027 | |
140 | Ubiquitination | SVLMRRQKQINYGKN HHHHHHHHHHHCCCC | 51.86 | - | |
146 | Ubiquitination | QKQINYGKNTIAYDR HHHHHCCCCCHHHHH | 40.32 | - | |
146 | Sumoylation | QKQINYGKNTIAYDR HHHHHCCCCCHHHHH | 40.32 | - | |
146 | Sumoylation | QKQINYGKNTIAYDR HHHHHCCCCCHHHHH | 40.32 | - | |
153 | Methylation | KNTIAYDRYIKEVPR CCCHHHHHHHHHCHH | 23.54 | 115368087 | |
156 | Ubiquitination | IAYDRYIKEVPRHLR HHHHHHHHHCHHHHC | 43.66 | - | |
171 | Phosphorylation | QPGIHPKTPNKFKKY CCCCCCCCCCHHHHC | 36.22 | 23401153 | |
178 | Phosphorylation | TPNKFKKYSRRSWDQ CCCHHHHCCCCCHHH | 14.17 | - | |
179 | Phosphorylation | PNKFKKYSRRSWDQQ CCHHHHCCCCCHHHH | 30.05 | 22617229 | |
182 | Phosphorylation | FKKYSRRSWDQQIKL HHHCCCCCHHHHHHH | 33.62 | 30266825 | |
217 | Phosphorylation | IHPVDLESAESSSEP ECCCCHHHCCCCCCC | 44.63 | 26074081 | |
220 | Phosphorylation | VDLESAESSSEPQTS CCHHHCCCCCCCCCC | 38.59 | 26074081 | |
221 | Phosphorylation | DLESAESSSEPQTSS CHHHCCCCCCCCCCC | 30.17 | 26074081 | |
222 | Phosphorylation | LESAESSSEPQTSSQ HHHCCCCCCCCCCCC | 63.68 | 26074081 | |
226 | Phosphorylation | ESSSEPQTSSQDDFD CCCCCCCCCCCCCCC | 40.85 | 26074081 | |
227 | Phosphorylation | SSSEPQTSSQDDFDV CCCCCCCCCCCCCCC | 22.28 | 26074081 | |
228 | Phosphorylation | SSEPQTSSQDDFDVY CCCCCCCCCCCCCCC | 40.80 | 26074081 | |
235 | Phosphorylation | SQDDFDVYSGTPTKV CCCCCCCCCCCCCEE | 11.83 | 26074081 | |
236 | Phosphorylation | QDDFDVYSGTPTKVR CCCCCCCCCCCCEEE | 35.72 | 26074081 | |
238 | Phosphorylation | DFDVYSGTPTKVRHM CCCCCCCCCCEEECC | 23.11 | 29496963 | |
240 | Phosphorylation | DVYSGTPTKVRHMDS CCCCCCCCEEECCCC | 41.85 | 28464451 | |
247 | Phosphorylation | TKVRHMDSQVEDEFD CEEECCCCCCCCCCC | 28.66 | 28464451 | |
260 | Phosphorylation | FDLEACLTEPLRDFS CCHHHHHCCCCHHHH | 35.13 | 24719451 | |
270 | Phosphorylation | LRDFSAMS------- CHHHHCCC------- | 36.47 | 26074081 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SLBP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ERI1_HUMAN | ERI1 | physical | 14536070 | |
ZN473_HUMAN | ZNF473 | physical | 11782445 | |
RENT1_HUMAN | UPF1 | physical | 16086026 | |
FEM1A_HUMAN | FEM1A | physical | 28118078 | |
FEM1B_HUMAN | FEM1B | physical | 28118078 | |
FEM1C_HUMAN | FEM1C | physical | 28118078 | |
CUL2_HUMAN | CUL2 | physical | 28118078 | |
NCBP1_HUMAN | NCBP1 | physical | 28118078 | |
CTIF_HUMAN | CTIF | physical | 28118078 | |
CCNF_HUMAN | CCNF | physical | 28118078 | |
CCNA2_HUMAN | CCNA2 | physical | 28118078 | |
RENT1_HUMAN | UPF1 | physical | 28118078 | |
DCA11_HUMAN | DCAF11 | physical | 27254819 | |
CUL4A_HUMAN | CUL4A | physical | 27254819 | |
CCNF_HUMAN | CCNF | physical | 27773672 | |
SKP1_HUMAN | SKP1 | physical | 27773672 | |
CDK1_HUMAN | CDK1 | physical | 27773672 | |
CDK2_HUMAN | CDK2 | physical | 27773672 | |
CCNA2_HUMAN | CCNA2 | physical | 27773672 | |
IF4G1_HUMAN | EIF4G1 | physical | 27773672 | |
RENT1_HUMAN | UPF1 | physical | 27773672 | |
TUT7_HUMAN | ZCCHC6 | physical | 27773672 | |
MI4GD_HUMAN | MIF4GD | physical | 27773672 | |
NCBP1_HUMAN | NCBP1 | physical | 27773672 | |
CSK21_HUMAN | CSNK2A1 | physical | 27773672 | |
CSK22_HUMAN | CSNK2A2 | physical | 27773672 | |
CUL1_HUMAN | CUL1 | physical | 27773672 | |
CTIF_HUMAN | CTIF | physical | 27773672 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20 AND SER-23, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-23 AND SER-182,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20 AND SER-23, AND MASSSPECTROMETRY. | |
"Phosphorylation of threonine 61 by cyclin a/Cdk1 triggers degradationof stem-loop binding protein at the end of S phase."; Koseoglu M.M., Graves L.M., Marzluff W.F.; Mol. Cell. Biol. 28:4469-4479(2008). Cited for: PHOSPHORYLATION AT THR-61 AND THR-62, MUTAGENESIS OF THR-61; THR-62;59-SER--PRO-63 AND 96-LYS--LEU-99, AND IDENTIFICATION BY MASSSPECTROMETRY. | |
"Phosphorylation of stem-loop binding protein (SLBP) on two threoninestriggers degradation of SLBP, the sole cell cycle-regulated factorrequired for regulation of histone mRNA processing, at the end of Sphase."; Zheng L., Dominski Z., Yang X.-C., Elms P., Raska C.S., Borchers C.H.,Marzluff W.F.; Mol. Cell. Biol. 23:1590-1601(2003). Cited for: FUNCTION, ASSOCIATION WITH POLYRIBOSOMES, SUBCELLULAR LOCATION,PHOSPHORYLATION AT THR-61 AND THR-62, RNA-BINDING, MUTAGENESIS OFSER-59; THR-61; THR-62; PRO-63 AND 96-LYS--LEU-99, AND IDENTIFICATIONBY MASS SPECTROMETRY. |